- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02736682
Single Dose Ceftriaxone and Metronidazole Versus Multiple Doses for Antibiotic Prophylaxis at Elective Cesarean Section. (SDvMD)
Single Dose Ceftriaxone and Metronidazole Versus Multiple Doses for Antibiotic Prophylaxis at Elective Cesarean Section in Mulago Hospital. A Randomized Clinical Trial.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This is going to be an open label randomized controlled clinical trial that will involve 174 mothers delivered by elective cesarean section in Mulago National Referral hospital ward 5B antenatal and post natal wards.
Mulago hospital is at the apex of a 6 tier health system and is the largest public hospital with 31,400 deliveries annually 26.14% by cesarean section and of these 5.6% are elective cesarean sections.
Simple randomization was done where 174 cards were numbered 1-174 {(87 labelled Single Dose (SD) and 87 labelled Multiple Dose (MD)} inserted in an envelop shuffled and then the mother was allowed to pick a card randomly. This was done by the research assistant who reviewed the mother again in theater to ascertain if they still met the eligibility before the intervention was done.
Method This will be an open label single center superiority randomized clinical trial involving 174 eligible participants (87 in each arm) who will have delivered by elective cesarean section in Mulago hospital. They will be randomly allocated into two arms. One arm will receive single dose IV ceftriaxone 2g and metronidazole 500mg 30-60 minutes before the operation and the second arm will receive IV ceftraixone 1g with 500 mg of metronidazole during the operation and continue for 72 hours and discharged with oral antibiotics.
The mothers will be reviewed twice daily for evidence of infection. Their vitals (BP, Pulse, Temperature and respiratory rate), state of the wound and uterus, amount color and smell of the lochia during the first 2-3 post operative days. Both arms will have a 14 day follow up where they will come back for review on the 7th and 14th post operative day.
Objective:
The general objective is to compare the incidence of post operative infections among mothers that receive single dose pre operative Ceftriaxone and metronidazole compared to multiple doses at delivery by elective cesarean section in Mulago National Referral Hospital. at 14 day post operative.
Type d'étude
Inscription (Réel)
Phase
- Phase 4
Contacts et emplacements
Lieux d'étude
-
-
-
Kampala, Ouganda, 00256
- Mulago National Refferal Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Antenatal mothers who have an indication for elective cesarean section in New Mulago hospital.
Exclusion Criteria:
- Mothers who have a history of allergy to any of the drugs in the study, Mother with visible infection at any site or elevated body temperature before going to theatre, Those with rapture of membranes, Mothers who went into labor, Mother who has had use of antibiotics in the last 7 days, WHO Clinical HIV stage III and IV and mothers who do not consent to the study.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Single dose antibiotic
2g of intra venous Ceftriaxone and 500 mgs Intra venous metronidazole is administered to the mothers as a Single dose pre-operative30-60 minutes before surgery.
|
Single dose arm receive 2g of IV Ceftriaxone and 500 mgs ofIntra venous Metronidazole given to the mothers 30-60 minutes pre operative.
Autres noms:
|
Comparateur actif: multiple dose antibiotic.
Multiple doses of IV Ceftriaxone 1g and metronidazole 500mgs given to the mother during surgery there after Ceftriaxone 1g every day for 3 days and IV metronidazole 500 mgs every 8 hours for 3 days.
|
Multiple dose arm receive 1 g of IV Cetriaxone plus 500 mgs during surgery and there after IV ceftriaxone once a day for 3 days and IV Metronidazole 500mgs during surgery and there after every 8 hours for 3 days.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Post operative wound infections
Délai: 14 days
|
Compare for incidence of post operative wound infection among mothers that receive single dose versus multiple dose antibiotics
|
14 days
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
clinical endometritis
Délai: 14 days
|
Compare the incidence of clinical endometritis among mothers that receive single versus multiple dose antibiotics
|
14 days
|
febrile morbidity
Délai: 14 days
|
compare the incidence of post operative febrile morbidity among mothers that receive single versus multiple doses
|
14 days
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Mugisa Alex Gideon, MBChB., Makerere University Collage of Health Sciences, Department of Obstetrics and Gynecology
- Directeur d'études: Paul Kiondo, MD, MMeD,PhD, Makerere University Collage of Health Sciences, Department of Obstetrics and Gynecology
- Directeur d'études: Imelda Namagembe, MD, MMeD, MPH, Mulago National Referral Hospital
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2013/HD07/658U
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Post Operative Infections
-
Vanderbilt UniversitySage Products, Inc.ComplétéInfections du site opératoire | Complication post-opératoireÉtats-Unis
-
Boston UniversityFogarty International Center of the National Institute of Health; Right to...ComplétéInfection néonatale | Infection post-partumZambie
-
Johann Wolfgang Goethe University HospitalComplétéTaux d'infection péristomiale | Saignement post-interventionnel | Taux de mortalité post-interventionnelleAllemagne
-
New York Medical CollegeActif, ne recrute pas
-
Olivia Cardenas-Trowers, M.D.AMAG Pharmaceuticals, Inc.RetiréMénopause | Post-ménopause | Infection urinaire récurrente | Symptômes post-ménopausiques | Syndrome post-ménopausiqueÉtats-Unis
-
Dartmouth-Hitchcock Medical CenterPSI MedicalComplété
-
National Taiwan University HospitalInconnueInfection post-splénectomie écrasanteTaïwan
-
Hampshire Hospitals NHS Foundation TrustRecrutementCancer péritonéal | Infection post-splénectomieRoyaume-Uni
-
Helsinki University Central HospitalUniversity of Turku; Oulu University Hospital; Kuopio University Hospital; Tampere...RecrutementHystérectomie | Antibiotiques | Infection post-opératoire | ProphylactiqueFinlande
-
William Wiley, MDComplétéInfection post-interventionnelleÉtats-Unis
Essais cliniques sur Single dose antibiotic
-
Tan Tock Seng HospitalNational Healthcare Group Polyclinics; Temasek PolytechnicComplétéRésistance antimicrobienneSingapour
-
Kenneth HargreavesRetiréRégénération de la pulpe dentaireÉtats-Unis
-
BioSyngen Pte LtdThe First Affiliated Hospital of Zhengzhou UniversityRecrutementTumeurs gastro-intestinalesChine
-
Beijing Northland Biotech. Co., Ltd.ComplétéInfarctus aigu du myocardeChine
-
Innovent Biologics (Suzhou) Co. Ltd.Complété
-
AblynxComplétéVolontaires en bonne santéÉtats-Unis
-
Medy-ToxComplétéLignes canthales latérales | Rides glabellairesÉtats-Unis, Fédération Russe, Allemagne, Canada, Belgique, Royaume-Uni
-
Beijing Northland Biotech. Co., Ltd.ComplétéInfarctus aigu du myocardeChine
-
Novo Nordisk A/SComplétéDiabète de type 2 | Volontaires en bonne santéÉtats-Unis, Canada
-
Medigene AGRetiréLeucémie myéloïde aiguë | Syndromes myélodysplasiques | Troubles myéloprolifératifs | Myélome multiple | Myélofibrose | La leucémie myéloïde chronique | Leucémie lymphoïde aiguë | Lymphome malinPays-Bas